Rose Lai

4.4k total citations
45 papers, 2.0k citations indexed

About

Rose Lai is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Rose Lai has authored 45 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 15 papers in Pulmonary and Respiratory Medicine and 13 papers in Molecular Biology. Recurrent topics in Rose Lai's work include Glioma Diagnosis and Treatment (16 papers), Brain Metastases and Treatment (8 papers) and CNS Lymphoma Diagnosis and Treatment (6 papers). Rose Lai is often cited by papers focused on Glioma Diagnosis and Treatment (16 papers), Brain Metastases and Treatment (8 papers) and CNS Lymphoma Diagnosis and Treatment (6 papers). Rose Lai collaborates with scholars based in United States, Canada and China. Rose Lai's co-authors include Lisa M. DeAngelis, Lauren E. Abrey, Marc K. Rosenblum, Denise D. Correa, Joachim Yahalom, Gaurav Shah, Jeffrey J. Raizer, Barbara Grant, David Schiff and Lehana Thabane and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Blood.

In The Last Decade

Rose Lai

45 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rose Lai United States 20 908 793 643 498 397 45 2.0k
Outi Kuittinen Finland 23 526 0.6× 530 0.7× 1.3k 2.0× 309 0.6× 198 0.5× 104 2.0k
Jayant Sastri Goda India 21 318 0.4× 257 0.3× 335 0.5× 323 0.6× 299 0.8× 90 1.4k
Frank Hartmann Germany 25 319 0.4× 268 0.3× 954 1.5× 561 1.1× 233 0.6× 82 2.8k
Alberto Donfrancesco Italy 26 271 0.3× 752 0.9× 159 0.2× 963 1.9× 413 1.0× 82 2.2k
George E. Georges United States 29 641 0.7× 97 0.1× 436 0.7× 597 1.2× 312 0.8× 106 3.1k
L. S. Lashford United Kingdom 23 950 1.0× 622 0.8× 50 0.1× 687 1.4× 388 1.0× 47 1.9k
Elvis Terci Valera Brazil 18 368 0.4× 227 0.3× 118 0.2× 725 1.5× 144 0.4× 108 1.4k
Lorenzo De Paoli Italy 15 771 0.8× 104 0.1× 650 1.0× 254 0.5× 137 0.3× 47 1.2k
Dae Won Kim South Korea 18 203 0.2× 238 0.3× 105 0.2× 315 0.6× 297 0.7× 74 1.6k
M. Raphael Pfeffer Israel 20 158 0.2× 225 0.3× 172 0.3× 242 0.5× 338 0.9× 51 1.5k

Countries citing papers authored by Rose Lai

Since Specialization
Citations

This map shows the geographic impact of Rose Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rose Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rose Lai more than expected).

Fields of papers citing papers by Rose Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rose Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rose Lai. The network helps show where Rose Lai may publish in the future.

Co-authorship network of co-authors of Rose Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Rose Lai. A scholar is included among the top collaborators of Rose Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rose Lai. Rose Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pérol, M., Wei Li, Nathan A. Pennell, et al.. (2025). Taletrectinib in ROS1 + Non–Small Cell Lung Cancer: TRUST. Journal of Clinical Oncology. 43(16). 1920–1929. 10 indexed citations
2.
3.
Sun, Wei, et al.. (2025). The association between myopia and mental health among Chinese children in primary and secondary school: a cross-sectional study. Frontiers in Public Health. 13. 1598790–1598790. 1 indexed citations
4.
Liu, Geoffrey, Yuichiro Ohe, Shunichi Sugawara, et al.. (2024). MA06.03 Efficacy and Safety of Taletrectinib in Patients with ROS1+ Non-Small Cell Lung Cancer: The Global TRUST-II Study. Journal of Thoracic Oncology. 19(10). S72–S73. 3 indexed citations
5.
Ali, Mourad W., Matthew A.M. Devall, Christopher H. Dampier, et al.. (2021). A Functional Variant on 9p21.3 Related to Glioma Risk Affects Enhancer Activity and Modulates Expression of CDKN2B‐AS1. Human Mutation. 42(10). 1208–1214. 7 indexed citations
6.
Nousome, Darryl, et al.. (2021). Meta-Analyses of Splicing and Expression Quantitative Trait Loci Identified Susceptibility Genes of Glioma. Frontiers in Genetics. 12. 609657–609657. 8 indexed citations
7.
Cornish, Alex J., Ben Kinnersley, Philip Law, et al.. (2020). Searching for causal relationships of glioma: a phenome-wide Mendelian randomisation study. British Journal of Cancer. 124(2). 447–454. 9 indexed citations
8.
Lai, Rose & Robert Van Order. (2019). International Real Estate Review. International Real Estate Review. 22(3). 359–397. 1 indexed citations
9.
10.
Lai, Rose, Yanwen Chen, Xiaowei Guan, et al.. (2014). Genome-Wide Methylation Analyses in Glioblastoma Multiforme. PLoS ONE. 9(2). e89376–e89376. 44 indexed citations
11.
Morris, Patrick G., Denise D. Correa, Joachim Yahalom, et al.. (2013). Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome. Journal of Clinical Oncology. 31(31). 3971–3979. 316 indexed citations
12.
Fong, Eliza Li Shan, et al.. (2012). The prevalence of lower urinary tract symptoms and treatment-seeking behaviour in males over 40 years in Singapore: a community-based study. Prostate Cancer and Prostatic Diseases. 15(3). 273–277. 23 indexed citations
13.
Ferris, Jennifer S., Lucie McCoy, Alfred I. Neugut, Margaret Wrensch, & Rose Lai. (2012). HMG CoA reductase inhibitors, NSAIDs and risk of glioma. International Journal of Cancer. 131(6). E1031–7. 41 indexed citations
14.
Cetani, Filomena, Claudio Marcocci, Elena Pardi, et al.. (2012). Multiple endocrine neoplasia syndrome type 1 (MEN-1) in Sardinian population: low prevalence of Men-1 mutations and detection of a new inactivating mutation of the CDKI gene p27. 15th International & 14th European Congress of Endocrinology. 29(5). 665–9. 1 indexed citations
15.
Bruce, Jeffrey N., Robert L. Fine, Peter Canoll, et al.. (2011). Regression of Recurrent Malignant Gliomas With Convection-Enhanced Delivery of Topotecan. Neurosurgery. 69(6). 1272–1280. 117 indexed citations
16.
Lai, Rose, Dawn L. Hershman, Thuy Doan, & Alfred I. Neugut. (2009). The timing of cranial radiation in elderly patients with newly diagnosed glioblastoma multiforme. Neuro-Oncology. 12(2). 190–198. 50 indexed citations
17.
Welch, Mary & Rose Lai. (2009). Glioblastoma multiforme. Current Treatment Options in Neurology. 11(4). 297–305. 2 indexed citations
18.
Lai, Rose. (2008). Survival of patients with adult medulloblastoma. Cancer. 112(7). 1568–1574. 57 indexed citations
19.
Lai, Rose, Chau T. Dang, Mark G. Malkin, & Lauren E. Abrey. (2004). The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma. Cancer. 101(4). 810–816. 121 indexed citations
20.
Kumar, Sushil, K. G. Mukerji, & Rose Lai. (1996). Molecular Aspects of Pesticide Degradation by Microorganisms. Critical Reviews in Microbiology. 22(1). 1–26. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Outi Kuittinen Breakdown of academic impact, for papers by Jayant Sastri Goda Breakdown of academic impact, for papers by Frank Hartmann Breakdown of academic impact, for papers by Alberto Donfrancesco Breakdown of academic impact, for papers by George E. Georges Breakdown of academic impact, for papers by L. S. Lashford Breakdown of academic impact, for papers by Elvis Terci Valera Breakdown of academic impact, for papers by Lorenzo De Paoli Breakdown of academic impact, for papers by Dae Won Kim Breakdown of academic impact, for papers by M. Raphael Pfeffer
Rankless by CCL
2026